177 related articles for article (PubMed ID: 37509275)
1. Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1.
Pride NA; Haebich KM; Walsh KS; Lami F; Rouel M; Maier A; Chisholm AK; Lorenzo J; Hearps SJC; North KN; Payne JM
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509275
[TBL] [Abstract][Full Text] [Related]
2. Delineating the autistic phenotype in children with neurofibromatosis type 1.
Chisholm AK; Haebich KM; Pride NA; Walsh KS; Lami F; Ure A; Maloof T; Brignell A; Rouel M; Granader Y; Maier A; Barton B; Darke H; Dabscheck G; Anderson VA; Williams K; North KN; Payne JM
Mol Autism; 2022 Jan; 13(1):3. PubMed ID: 34983638
[TBL] [Abstract][Full Text] [Related]
3. Sensory processing in 16p11.2 deletion and 16p11.2 duplication.
Smith H; Lane C; Al-Jawahiri R; Freeth M
Autism Res; 2022 Nov; 15(11):2081-2098. PubMed ID: 36053814
[TBL] [Abstract][Full Text] [Related]
4. Sensory processing in Sotos syndrome and Tatton-Brown-Rahman Syndrome.
Smith H; Lane C; Al-Jawahiri R; Freeth M
J Psychopathol Clin Sci; 2023 Aug; 132(6):768-778. PubMed ID: 37289542
[TBL] [Abstract][Full Text] [Related]
5. The mediating role of ADHD symptoms between executive function and social skills in children with neurofibromatosis type 1.
Haebich KM; Dao DP; Pride NA; Barton B; Walsh KS; Maier A; Chisholm AK; Darke H; Catroppa C; Malarbi S; Wilkinson JC; Anderson VA; North KN; Payne JM
Child Neuropsychol; 2022 Apr; 28(3):318-336. PubMed ID: 34587865
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial functioning, self-image, and quality of life in children and adolescents with neurofibromatosis type 1.
Cipolletta S; Spina G; Spoto A
Child Care Health Dev; 2018 Mar; 44(2):260-268. PubMed ID: 28776749
[TBL] [Abstract][Full Text] [Related]
7. Attention Deficit Predicts Intellectual Functioning in Children with Neurofibromatosis Type 1.
Heimgärtner M; Granström S; Haas-Lude K; Leark RA; Mautner VF; Lidzba K
Int J Pediatr; 2019; 2019():9493837. PubMed ID: 31915440
[TBL] [Abstract][Full Text] [Related]
8. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
[TBL] [Abstract][Full Text] [Related]
9. Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1.
Payne JM; Haebich KM; MacKenzie R; Walsh KS; Hearps SJC; Coghill D; Barton B; Pride NA; Ullrich NJ; Tonsgard JH; Viskochil D; Schorry EK; Klesse L; Fisher MJ; Gutmann DH; Rosser T; Packer RJ; Korf B; Acosta MT; Bellgrove MA; North KN
J Atten Disord; 2021 Jun; 25(8):1177-1186. PubMed ID: 31838937
[No Abstract] [Full Text] [Related]
10. Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
Morotti H; Mastel S; Keller K; Barnard RA; Hall T; O'Roak BJ; Fombonne E
Dev Med Child Neurol; 2021 Feb; 63(2):226-232. PubMed ID: 32406525
[TBL] [Abstract][Full Text] [Related]
11. Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.
Pierpont EI; Hudock RL; Foy AM; Semrud-Clikeman M; Pierpont ME; Berry SA; Shanley R; Rubin N; Sommer K; Moertel CL
J Neurodev Disord; 2018 Jun; 10(1):21. PubMed ID: 29914349
[TBL] [Abstract][Full Text] [Related]
12. Sensory modulation and affective disorders in children and adolescents with Asperger's disorder.
Pfeiffer B; Kinnealey M; Reed C; Herzberg G
Am J Occup Ther; 2005; 59(3):335-45. PubMed ID: 15969281
[TBL] [Abstract][Full Text] [Related]
13. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
[TBL] [Abstract][Full Text] [Related]
14. Reduced mismatch negativity in children and adolescents with autism spectrum disorder is associated with their impaired adaptive functioning.
Lassen J; Oranje B; Vestergaard M; Foldager M; Kjaer TW; Arnfred S; Aggernaes B
Autism Res; 2022 Aug; 15(8):1469-1481. PubMed ID: 35545929
[TBL] [Abstract][Full Text] [Related]
15. Social skills of children with neurofibromatosis type 1.
Barton B; North K
Dev Med Child Neurol; 2004 Aug; 46(8):553-63. PubMed ID: 15287247
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior.
Cavallo ND; Maggi G; Ferraiuolo F; Sorrentino A; Perrotta S; Carotenuto M; Santangelo G; Santoro C
Children (Basel); 2023 Feb; 10(2):. PubMed ID: 36832459
[TBL] [Abstract][Full Text] [Related]
17. Sensory integration therapy for children with autism and sensory processing difficulties: the SenITA RCT.
Randell E; Wright M; Milosevic S; Gillespie D; Brookes-Howell L; Busse-Morris M; Hastings R; Maboshe W; Williams-Thomas R; Mills L; Romeo R; Yaziji N; McKigney AM; Ahuja A; Warren G; Glarou E; Delport S; McNamara R
Health Technol Assess; 2022 Jun; 26(29):1-140. PubMed ID: 35766242
[TBL] [Abstract][Full Text] [Related]
18. Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms.
Huijbregts SC; Loitfelder M; Rombouts SA; Swaab H; Verbist BM; Arkink EB; Van Buchem MA; Veer IM
J Neurodev Disord; 2015; 7():32. PubMed ID: 26473019
[TBL] [Abstract][Full Text] [Related]
19. Visual-processing deficits in children with neurofibromatosis type 1: A clinical marker of reading difficulties.
Vernet M; Jover M; Bellocchi S; Maziero S; Jucla M; Tallet J; Danna J; Chaix Y; Ducrot S
Eur J Paediatr Neurol; 2022 May; 38():25-32. PubMed ID: 35381410
[TBL] [Abstract][Full Text] [Related]
20. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
Lorenzo J; Barton B; Arnold SS; North KN
J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
